The
RSO performed a quarterly audit on 9/2/08 and discovered that a misadministration greater than 20% of prescribed dose and greater than 50
Rem to the lung tissue occurred on 6/2/08. The prescribed dose was 1.0 ml of P-32 chromic phosphate into two separate syringe applications.
The technician prepared the first P-32 dose into syringe "A" and recorded into the written record after calibrated assay as 1.3 ml and performed the same procedure for the second dose which was recorded into the written record as 1.0 ml into syringe "B". The first dose in syringe "A" exceeded the allowable dose. Both syringe applications were given to the patient into separate lung tube injections.
The prescribing physician and authorized user have been notified. It is not known if the patient has been notified.
- * * RETRACTION AT 1545 EDT ON 9/5/08 FROM OYTOMARI TO SANDIN * * *
Based on further review of this event by the licensee, it was determined that the total dose to the lung was less than 50 Rem. As a result, the event does not meet reportability criteria under 10CFR35.3045. The licensee has reviewed its conclusion with NRC Region 4 inspectors (Whitten and Munoz).
R4DO (Jones) and
FSME (Turtil) have been notified.